ANDRÉS
ÍÑIGUEZ ROMO
Chercheur jusqu {1}
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro Nacional de Investigaciones Cardiovasculares Carlos III (7)
2021
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041
2020
-
Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design
American Heart Journal, Vol. 222, pp. 174-182
2014
-
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)
Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362
-
Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"
Circulation
2013
-
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial
Circulation, Vol. 128, Núm. 14, pp. 1495-1503
2012
-
Study design for the effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion (METOCARD-CNIC): A randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction
American Heart Journal, Vol. 164, Núm. 4
2011
-
Modulation of the beta-adrenergic system during acute myocardial infarction: Rationale for a new clinical trial
Revista Espanola de Cardiologia, Vol. 64, Núm. SUPPL. 2, pp. 28-33